Chemical Compound
Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-; N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide; G 02442104; GSK 1120212; GSK 212; JTP 74057; Mekinist; N-[3-[3-Cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide; Trametinib; Trametinib related; GSK 1120212A
CAS Registry Number
871700-17-3
Primary record
Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-; N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide; G 02442104; GSK 1120212; GSK 212; JTP 74057; Mekinist; N-[3-[3-Cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide; Trametinib; Trametinib related; GSK 1120212A
- 库存
- 1,349 克
- 纯度
- 98.8 %
- CAS
- 871700-17-3
化合物标识与属性
- CAS
- 871700-17-3
- PubChem CID
- 11707110
- SMILES
- CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
- Canonical SMILES
- CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1
名称与同义词
- Trametinib
- Mekinist
- 871700-17-3
- GSK1120212
- trametinibum
- Trametinib?
- GSK-1120212
- Trametinib (GSK1120212)
- Trametinib [USAN]
- JTP 74057
- T-nib
- JTP-74057
- Trametinib (USAN)
- GSK 1120212
- TMT212
- Trametinib (Standard)
- Trametinib [USAN:INN]
- GSK212
- RefChem:57975
- TRAMETINIB [MI]
- MFCD17215075
- TRAMETINIB [INN]
- TMT-212
- C26H23FIN5O4
- TRAMETINIB [VANDF]
- cc-37
- CHEBI:75998
- D04XVN
- D0F5RQ
- UNII-33E86K87QN
- Trametinib (MEK inhibitor)
- 33E86K87QN
- TRAMETINIB [WHO-DD]
- JTP74057
- SCHEMBL170938
- GTPL6495
- orb1306425
- QCR-39
- GSK1120212 (Trametinib)
- CHEMBL2103875
- MEK Inhibitor GSK1120212
- SCHEMBL29355100
- SCHEMBL29363416
- TRAMETINIB DIMETHYL SULFOXIDE
- GSK1120212B
- EX-A022
- L01XE25
- LIRYPHYGHXZJBZ-UHFFFAOYSA-N
- BCPP000218
- DTXSID901007381
- GLXC-90070
- HMS3295I05
- HMS3656J11
- HMS5081N13
- AOB87707
- BCP02307
- ABP000312
- AN-539
- BDBM50531540
- EBC-17166
- HY-10999R
- NSC758246
- NSC800956
- RW4149
- s2673
- ZINC43100709
- AKOS015850628
- N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide
- ACN-041327
- AM90271
- CCG-264976
- CS-0060
- DB08911
- EX-5957
- FC34128
- NSC-758246
- NSC-800956
- RL05418
- SB16553
- SDCCGSBI-0646933.P001
- Trametinib (GSK1120212JTP 74057)
- CID11707110
- NCGC00263180-01
- NCGC00263180-07
- NCGC00263180-14
- 4CA-0583
- AC-25891
- AK174783
- AS-19382
- BC638742
- BP-44059
- CID 11707110
- CID:11707110
- HY-10999
- SC-85458
- SY067882
- SID:160778567
- AB0008115
- A3018
- FT-0688438
- NS00040692
- SW218089-2
- X7454
- J3.135.455B
- KS-00000002
- A11029
- A25168
- D10175
- GSK1120212 - JTP-74057
- S-7800
- GSK-1120212/GSK1120212/
- N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide
- C560077
- EN300-25299821
- GSK1120212,JTP-74057, GSK212
- SR-01000941589
- N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide
- Q7833138
- SR-01000941589-1
- BRD-K12343256-001-01-4
- BRD-K12343256-001-08-9
- BRD-K12343256-001-11-3
- BRD-K12343256-001-14-7
- BRD-K12343256-001-18-8
- N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amin
- Trametinib, 98%, a MEK1/2 inhibitor - 10MG 10mg
- JTP-74057, 871700-17-3
- N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
- B0084-307744
- N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodo-anilino)-6,8-dimethyl-2,4,7-trioxo-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
- N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-1H,2H,3H,4H,6H,7H-pyrido[4,3-d]pyrimidin-1-yl}phenyl)acetamide
- 1187431-43-1
- 3 -[3-Cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidine-1(2H)-yl]acetoanilide
- Acetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8- dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-
- Acetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-
- Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-
- Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-; N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide; G 02442104; GSK 1120212; GSK 212; JTP 74057; Mekinist; N-[3-[3-Cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide; Trametinib; Trametinib related; GSK 1120212A
- Acetamide,N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-
- N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-1H,2H,3H,4H,6H,7H-pyrido(4,3-d)pyrimidin-1-yl)phenyl)acetamide
- N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)acetamide
- N-(3-(3-CYCLOPROPYL-5-((2-FLUORO-4-IODOPHENYL)AMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDROPYRIDO(4,3-D)PYRIMIDIN-1(2H)-YL)PHENYL)ACETAMIDE
- N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxopyrido(3,4-e)pyrimidin-1-yl)phenyl)acetamide
- N-(3-(3-Cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)pheny l)acetamide
- N-(3-(3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide
- N-(3-{3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl}phenyl)acetamide
- N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl}phenyl)acetamide
- N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4, 7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
- n-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyr
- N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidine-1(2H)-yl]phenyl]acetamide
- N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide
- N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidine-1(2H)-yl]phenyl]acetamide
- N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[3,4-e]pyrimidin-1-yl]phenyl]acetamide
- N-{3-[3-Cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl}ethanimidic acid
- N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide
- QOM